Rexulti 2 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FHXLW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $74,612
Award facts
- Contract value 100% obligated
- $74,612.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $74,612.17. This non-competitive delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025. Rexulti (brexpiprazole) is an atypical antipsychotic medication used in treating schizophrenia and depression, making this delivery order part of the agency's broader pharmaceutical supply chain supporting military and veteran healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has established itself as a critical vendor for federal medical procurement through its comprehensive portfolio of brand-name and generic medications, vaccines, and medical supplies. As the prime contractor under the DLA's Pharmaceutical Prime Vendor Global Program, the company supplies pharmaceutical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The delivery order represents a routine transaction within the established IDC framework, demonstrating AmerisourceBergen's capacity to fulfill federal medical supply requirements through open competition and firm fixed-price arrangements.
Quick answers
Who was awarded contract SPE2DB25FHXLW?
SPE2DB25FHXLW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FHXLW worth?
The government has obligated $74,612 on SPE2DB25FHXLW.
Is contract SPE2DB25FHXLW an order under another contract?
Yes. SPE2DB25FHXLW is a delivery order under SPE2DB24D2109, an indefinite delivery contract.
Was contract SPE2DB25FHXLW competed?
The extent of competition for SPE2DB25FHXLW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award